Ignyta Inc - Medical Equipment - Deals and Alliances Profile

Summary

Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes in cancer cells. It develops products using integrated therapeutic technology (Rx/Dx). Ignytas pipeline products include entrectinib, RXDX-105, taladegib and RXDX-106. The companys entrectinib product is designed to target cancers harboring activating molecular alterations. Its RXDX-106 is a novel small molecule immunomodulatory agent with potent anti-tumor activity. Ignyta offers clinical trials and research and development services. The company serves cancer patients and pharmaceuticals industries. Ignytais headquartered in San Diego, California, the US.

Ignyta Inc - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

it derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Ignyta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ignyta Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ignyta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ignyta Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Ignyta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Ignyta Inc, Medical Equipment, Deal Details 10
Venture Financing 10
NexDx Raises US$5.5 Million In Series B Financing 10
Partnerships 11
NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 11
Equity Offering 12
Ignyta Prices Public Offering of Shares for USD160 Million 12
Acquisition 14
Roche Acquires Ignyta for USD1.7 Billion 14
Ignyta Inc - Key Competitors 16
Ignyta Inc - Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Financial Announcements 18
Nov 07, 2017: Ignyta Announces Third Quarter 2017 Company Highlights and Financial Results 18
May 01, 2017: Ignyta Announces First Quarter 2017 Company Highlights and Financial Results 20
Mar 14, 2017: Ignyta Announces Full Year 2016 Company Highlights and Financial Results 22
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List Of Tables


Ignyta Inc, Medical Equipment, Key Facts 2
Ignyta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Ignyta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ignyta Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Ignyta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ignyta Inc, Deals By Market, 2012 to YTD 2018 8
Ignyta Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
NexDx Raises US$5.5 Million In Series B Financing 10
NexDx Enters Into Licensing Agreement With University of California For Epigenetic Biomarkers 11
Ignyta Prices Public Offering of Shares for USD160 Million 12
Roche Acquires Ignyta for USD1.7 Billion 14
Ignyta Inc, Key Competitors 16

List Of Figures


Ignyta Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Ignyta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Ignyta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Ignyta Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Ignyta Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Ignyta Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Ignyta Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Ignyta Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

Ignyta Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes

USD 250 View Report

Ignyta Inc - Medical Equipment - Deals and Alliances Profile

Ignyta Inc (Ignyta), formerly NexDx Inc, a subsidiary of F. Hoffmann-La Roche Ltd, is a cancer care service provider. The company discovers, develops and commercializes new drugs targeting activated genes

USD 250 View Report

Bioverativ Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bioverativ Inc (Bioverativ) is a biotechnology company that discovers, develops, and markets therapeutics for the treatment of hemophilia, and rare blood disorders. Its product portfolio includes Eloctate, which comprises recombinant

USD 250 View Report

AOL Inc - Strategic SWOT Analysis Review

AOL Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on

USD 125 View Report

Your are not allow to send sample request

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available